Johnson & Johnson (JNJ) FCF Margin (QoQ) (2009 - 2026)

Johnson & Johnson (JNJ) FCF Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 -1,619.00
Dec 28, 2025 -1,112.00
Sep 28, 2025 2,145.00
Jun 29, 2025 -349.00
Mar 30, 2025 -842.00
Dec 29, 2024 -714.00
Sep 29, 2024 1,024.00
Jun 30, 2024 742.00
Mar 31, 2024 -1,600.00
Dec 31, 2023 -122.00
Oct 1, 2023 1,634.00
Jul 2, 2023 275.00
Apr 2, 2023 271.00
Oct 3, 2021 1,301.00
Jul 4, 2021 409.00
Apr 4, 2021 -1,602.00
Jan 3, 2021 -503.00
Sep 27, 2020 2,105.00
Jun 28, 2020 201.00
Mar 29, 2020 -1,156.00